<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Steroidal contraceptives: effect on bone fractures in women - Lopez, LM - 2014 | Cochrane Library</title> <meta content="Steroidal contraceptives: effect on bone fractures in women - Lopez, LM - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006033.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Steroidal contraceptives: effect on bone fractures in women - Lopez, LM - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006033.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006033.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Steroidal contraceptives: effect on bone fractures in women" name="citation_title"/> <meta content="Laureen M Lopez" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="llopez@fhi360.org" name="citation_author_email"/> <meta content="David A Grimes" name="citation_author"/> <meta content="University of North Carolina, School of Medicine" name="citation_author_institution"/> <meta content="Kenneth F Schulz" name="citation_author"/> <meta content="FHI 360 and UNC School of Medicine" name="citation_author_institution"/> <meta content="Kathryn M. Curtis" name="citation_author"/> <meta content="Centers for Disease Control and Prevention" name="citation_author_institution"/> <meta content="Mario Chen" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD006033.pub5" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/06/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006033.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006033.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006033.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bone Density [*drug effects]; Bone Remodeling [drug effects]; Contraceptives, Oral, Hormonal [adverse effects, *pharmacology]; Estrogens [pharmacology]; Fractures, Bone [*chemically induced]; Medroxyprogesterone Acetate [adverse effects, pharmacology]; Premenopause; Progestins [pharmacology]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006033.pub5&amp;doi=10.1002/14651858.CD006033.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="QzbxnhyM";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006033\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006033\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006033.pub5",title:"Steroidal contraceptives: effect on bone fractures in women",firstPublishedDate:"Jun 24, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Fertility Regulation Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006033.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006033.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006033.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006033.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006033.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006033.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006033.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006033.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006033.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006033.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4607 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006033.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-sec-0029"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/appendices#CD006033-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/table_n/CD006033StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/table_n/CD006033StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Steroidal contraceptives: effect on bone fractures in women</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Laureen M Lopez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-cr-0003">David A Grimes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-cr-0004">Kenneth F Schulz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-cr-0005">Kathryn M. Curtis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-cr-0006">Mario Chen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information/en#CD006033-sec-0097">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 June 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006033.pub5">https://doi.org/10.1002/14651858.CD006033.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006033-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006033-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006033-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006033-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006033-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006033-abs-0001" lang="en"> <section id="CD006033-sec-0001"> <h3 class="title" id="CD006033-sec-0001">Background</h3> <p>Steroidal contraceptive use has been associated with changes in bone mineral density in women. Whether such changes increase the risk of fractures later in life is not clear. Osteoporosis is a major public health concern. Age‐related decline in bone mass increases the risk of fracture, especially of the spine, hip, and wrist. Concern about bone health influences the recommendation and use of these effective contraceptives globally. </p> </section> <section id="CD006033-sec-0002"> <h3 class="title" id="CD006033-sec-0002">Objectives</h3> <p>Our aim was to evaluate the effect of using hormonal contraceptives before menopause on the risk of fracture in women. </p> </section> <section id="CD006033-sec-0003"> <h3 class="title" id="CD006033-sec-0003">Search methods</h3> <p>Through April 2014, we searched for studies of fracture or bone health and hormonal contraceptives in MEDLINE, POPLINE, CENTRAL, EMBASE, and LILACS, as well as ClinicalTrials.gov and ICTRP. We examined reference lists of relevant articles for other trials. For the initial review, we wrote to investigators to find additional trials. </p> </section> <section id="CD006033-sec-0004"> <h3 class="title" id="CD006033-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCTs) were considered if they examined fractures, bone mineral density (BMD), or bone turnover markers in women with hormonal contraceptive use prior to menopause. Eligible interventions included comparisons of a hormonal contraceptive with a placebo or with another hormonal contraceptive that differed in terms of drug, dosage, or regimen. They also included providing a supplement to one group. </p> </section> <section id="CD006033-sec-0005"> <h3 class="title" id="CD006033-sec-0005">Data collection and analysis</h3> <p>We assessed all titles and abstracts identified through the literature searches. Mean differences were computed using the inverse variance approach. For dichotomous outcomes, the Mantel‐Haenszel odds ratio (OR) was calculated. Both included the 95% confidence interval (CI) and used a fixed‐effect model. Due to differing interventions, no trials could be combined for meta‐analysis. We applied principles from GRADE to assess the evidence quality and address confidence in the effect estimates. In addition, a sensitivity analysis included trials that provided sufficient data for this review and evidence of at least moderate quality. </p> </section> <section id="CD006033-sec-0006"> <h3 class="title" id="CD006033-sec-0006">Main results</h3> <p>We found 19 RCTs that met our eligibility criteria. Eleven trials compared different combined oral contraceptives (COCs) or regimens of COCs; five examined an injectable versus another injectable, implant, or IUD; two studied implants, and one compared the transdermal patch versus the vaginal ring. No trial had fracture as an outcome. BMD was measured in 17 studies and 12 trials assessed biochemical markers of bone turnover. Depot medroxyprogesterone acetate (DMPA) was associated with decreased bone mineral density (BMD). The placebo‐controlled trials showed BMD increases for DMPA plus estrogen supplement and decreases for DMPA plus placebo supplement. COCs did not appear to negatively affect BMD, and some formulations had more positive effects than others. However, no COC trial was placebo‐controlled. Where studies showed differences between groups in bone turnover markers, the results were generally consistent with those for BMD. For implants, the single‐rod etonogestrel group showed a greater BMD decrease versus the two‐rod levonorgestrel group but results were not consistent across all implant comparisons. </p> <p>The sensitivity analysis included 11 trials providing evidence of moderate or high quality. Four trials involving DMPA showed some positive effects of an estrogen supplement on BMD, a negative effect of DMPA‐subcutaneous on lumbar spine BMD, and a negative effect of DMPA on a bone formation marker. Of the three COC trials, one had a BMD decrease for the group with gestodene plus EE 15 μg. Another indicated less bone resorption in the group with gestodene plus EE 30 μg versus EE 20 μg. </p> </section> <section id="CD006033-sec-0007"> <h3 class="title" id="CD006033-sec-0007">Authors' conclusions</h3> <p>Whether steroidal contraceptives influence fracture risk cannot be determined from existing information. The evidence quality was considered moderate overall, largely due to the trials of DMPA, implants, and the patch versus ring. The COC evidence varied in quality but was low overall. Many trials had small numbers of participants and some had large losses. Health care providers and women should consider the costs and benefits of these effective contraceptives. For example, injectable contraceptives and implants provide effective, long‐term birth control yet do not involve a daily regimen. Progestin‐only contraceptives are considered appropriate for women who should avoid estrogen due to medical conditions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006033-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006033-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006033-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006033-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006033-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006033-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pl#CD006033-abs-0007">Polski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006033-abs-0004" lang="en"> <h3>Hormonal contraceptives and bone health in women</h3> <p>Hormonal contraceptives have been related to bone changes in women. Whether such changes lead to more bone fractures later in life is not clear. However, bone health is a major public health concern. Bone density declines with age, and the change increases the risk of fracture. Due to concern about bone health, health care providers may not suggest hormonal contraceptives and women may not want to use them. </p> <p>Through April 2014, we did computer searches for studies of birth control methods containing hormones and risk of fractures. Outcomes could also be bone mineral density or markers of bone changes. Birth control pills included types with both estrogen and progestin. Also included were implants and injectables with only progestin. We wrote to researchers to find other trials. We included randomized trials in any language that had at least three treatment cycles. The studies had to compare two types of birth control or one type of birth control or a supplement with a placebo or 'dummy' method. </p> <p>We found 19 trials. Fifteen studies compared one birth control method with another hormone method. Two trials used a placebo or 'dummy.' One compared a hormone method to a method without hormones. None had fractures as an outcome and most looked at bone density. Birth control methods with both estrogen and progestin did not appear to affect bone health. However, 'depo,' which is injected and has only progestin, was related to lower bone density. The two depo trials with placebos showed increased bone density when some estrogen was given to women on depo. Bone density decreased in women who got a 'dummy' with the depo. Whether this decrease is important to the woman's health is not known. For implants, an etonogestrel implant with one rod showed a greater decrease in bone density than a two‐rod levonorgestrel implant. However, other implants studied did not show the same pattern. </p> <p>The studies had data of moderate quality. Whether hormonal contraceptives affect fracture risk cannot be judged from current information. These contraceptive methods work well for birth control. Health‐care providers and women should think about the costs and benefits. For instance, injectable use can occur without a partner's knowledge, and is simpler than taking pills every day. Also, progestin‐only methods are suggested for some women with health problems who should avoid estrogen. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006033-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006033-sec-0070"></div> <h3 class="title" id="CD006033-sec-0071">Implications for practice</h3> <section id="CD006033-sec-0071"> <p>Whether steroidal contraceptives influence fracture risk cannot be determined from existing information. Combination contraceptives do not appear to negatively affect bone mineral density or bone turnover markers. Of progestin‐only methods, DMPA may alter bone mineral density. Whether DMPA affects fracture risk cannot be determined, as no randomized trial assessed fracture. Health care providers and women should consider the costs and benefits of these effective contraceptives. The advantages of DMPA outweigh concerns about fracture risk for adolescents and for women over 45 years of age (<a href="./references#CD006033-bbs2-0070" title="World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Fourth Edition, 2009. http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html. Geneva: World Health Organization, (accessed 05 Dec 2011):45. ">WHO 2009</a>). Injectable contraceptives may be appropriate for women who want long‐term birth control without a daily regimen. Other candidates for progestin‐only contraceptives are women with contraindications to estrogen use. </p> </section> <h3 class="title" id="CD006033-sec-0072">Implications for research</h3> <section id="CD006033-sec-0072"> <p>Additional trials of estrogen supplementation with progestin‐only contraceptives would provide more evidence regarding any effect on bone health. Many trials had limitations for interpretation, including small numbers of participants and large losses. Stronger evidence is needed to make recommendations for clinical practice. Trials of longer duration could provide information on whether there was any reversal of earlier decreases in BMD. Studies could focus on adolescents, who have not yet reached peak bone mass, and on perimenopausal women, who may be losing bone mass. Results of such trials could help determine if these two groups are at greater risk of adverse outcomes due to the effects of progestin. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006033-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006033-sec-0022"></div> <section id="CD006033-sec-0023"> <h3 class="title" id="CD006033-sec-0023">Description of the condition</h3> <p>Steroidal contraceptives, particularly injectable contraceptives and combined oral contraceptives (COCs), have been associated with changes in bone mineral density in women. Whether such changes increase the risk of fractures later in life is not clear. However, osteoporosis is a major public health concern. Age‐related decline in bone mass increases the risk of fracture, especially of the spine, hip, and wrist (<a href="./references#CD006033-bbs2-0049" title="HoweTE , SheaB , DawsonLJ , DownieF , MurrayA , RossC , et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews. 2011/07/08 2011, issue 7:CD000333. ">Howe 2011</a>; <a href="./references#CD006033-bbs2-0058" title="RachnerTD , KhoslaS , HofbauerLC . Osteoporosis: now and the future. Lancet. 2011/04/01 2011; Vol. 377, issue 9773:1276‐87. ">Rachner 2011</a>). The costs of osteoporosis‐related fractures can be substantial for the individual due to disability and to society for health and social care (<a href="./references#CD006033-bbs2-0049" title="HoweTE , SheaB , DawsonLJ , DownieF , MurrayA , RossC , et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews. 2011/07/08 2011, issue 7:CD000333. ">Howe 2011</a>). Concern about bone health influences the recommendation and use of these effective contraceptives globally. </p> <p>Skeletal fragility results from suboptimal formation of bone mass and strength, as well as excess bone resorption (<a href="./references#CD006033-bbs2-0057" title="Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement 2000 March 27‐292000; Vol. 19, issue 1:1‐45. ">NIH 2000</a>; <a href="./references#CD006033-bbs2-0059" title="RaiszLG . Pathogenesis of osteoporosis: concepts, conflicts, and prospects. Journal of Clinical Investigation2005;115:3318‐25. ">Raisz 2005</a>). Bone loss during contraceptive use may be temporary like that which occurs during pregnancy or breastfeeding (<a href="./references#CD006033-bbs2-0043" title="GourlayML , BrownSA . Clinical considerations in premenopausal osteoporosis. Archives of Internal Medicine2004;164:603‐14. ">Gourlay 2004</a>; <a href="./references#CD006033-bbs2-0032" title="Committee on Adolescent Health, Committee on Gynecologic Practice. Depot medroxyprogesterone acetate and bone effects. Obstetrics and Gynecology2008;112:727‐30. ">ACOG 2008</a>). Risk of future fractures after contraceptive use depends on whether the bone mass is restored. </p> </section> <section id="CD006033-sec-0024"> <h3 class="title" id="CD006033-sec-0024">Description of the intervention</h3> <section id="CD006033-sec-0025"> <h4 class="title">Depot medroxyprogesterone acetate (DMPA)</h4> <p>DMPA is an effective contraceptive and the most widely‐used injectable (<a href="./references#CD006033-bbs2-0035" title="BartzD , GoldbergAB . Injectable contraceptives. In: HatcherRA , TrussellJ , NelsonAL , CatesW , KowalD , PolicarMS editor(s). Contraceptive Technology. 20th Edition. New York: Ardent Media, Inc., 2011:209‐36. ">Bartz 2011</a>). Data from developing countries showed median failure rates of 2.4% for injectables versus 10.3% for condoms and 6.5% for pills (<a href="./references#CD006033-bbs2-0037" title="ClelandJ , AliMM . Reproductive consequences of contraceptive failure in 19 developing countries. Obstetrics and Gynecology2004;104:314‐20. ">Cleland 2004</a>). First‐year failure rates for DMPA in the USA have been estimated at 0.2% for perfect use and 6% for typical use (<a href="./references#CD006033-bbs2-0062" title="TrussellJ . Contraceptive failure in the United States. Contraception2011;83:397‐404. ">Trussell 2011</a>). If injectable use were limited due to concerns about effects on bone health, women might switch to less effective methods or use nothing, which could lead to increased pregnancy rates. </p> <p>Of the injectable contraceptives, DMPA has attracted the most attention regarding bone health. DMPA may reduce bone mineral density (BMD), which is a potential concern for younger women who have not yet achieved peak bone mass. Early research indicated more bone loss among women who used DMPA before 20 years of age and those who used it for longer periods (<a href="./references#CD006033-bbs2-0040" title="CundyT , CornishJ , RobertsH , ElderH , ReidIR . Spinal bone density in women using depot medroxyprogesterone contraception. Obstetrics and Gynecology1998;92(4 Pt 1):569‐73. ">Cundy 1998</a>; <a href="./references#CD006033-bbs2-0060" title="ScholesD , LacroixAZ , OttSM , IchikawaLE , BarlowWE . Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstetrics and Gynecology1999;93:233‐8. ">Scholes 1999</a>). More recently, two case‐control studies reported increased fracture risk for longer current use of DMPA (<a href="./references#CD006033-bbs2-0067" title="VestergaardP , RejnmarkL , MosekildeL . Oral contraceptive use and risk of fracture. Contraception2006;73:571‐6. ">Vestergaard 2006</a>; <a href="./references#CD006033-bbs2-0054" title="MeierC , BrauchliYB , JickSS , KraenzlinME , MeierCR . Use of depot medroxyprogesterone acetate and fracture risk. Journal of Clinical Endocrinology and Metabolism. 2010/08/06 2010; Vol. 95, issue 11:4909‐16. ">Meier 2010</a>), although past users had little evidence of increased risk (<a href="./references#CD006033-bbs2-0054" title="MeierC , BrauchliYB , JickSS , KraenzlinME , MeierCR . Use of depot medroxyprogesterone acetate and fracture risk. Journal of Clinical Endocrinology and Metabolism. 2010/08/06 2010; Vol. 95, issue 11:4909‐16. ">Meier 2010</a>). </p> <p>In the US, the Food and Drug Administration requires a warning on DMPA labeling (<a href="./references#CD006033-bbs2-0041" title="U.S.Food , DrugAdministration . Safety. Depo‐Provera (medroxyprogesterone acetate injectable suspension). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154784.htm (accessed 05 Feb 2014). ">FDA 2004</a>; <a href="./references#CD006033-bbs2-0042" title="U.S.Food , DrugAdministration . Drugs@FDA: FDA Approved Drug Products. Depo‐Provera. Label and Approval History. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory (accessed 05 Feb 2014). ">FDA 2011</a>). It refers to BMD loss among DMPA users, especially younger women. The warning is based on limited evidence and may limit long‐term use (<a href="./references#CD006033-bbs2-0050" title="KaunitzA M , GrimesD A . Removing the black box warning for depot medroxyprogesterone acetate. Contraception2011;84:212‐3. ">Kaunitz 2011</a>). Major health organizations have recommended not restricting DMPA use among women 18 to 45 years old (<a href="./references#CD006033-bbs2-0069" title="World Health Organization. WHO statement on hormonal contraception and bone health. Contraception2006;73:443‐4. ">WHO 2006</a>; <a href="./references#CD006033-bbs2-0032" title="Committee on Adolescent Health, Committee on Gynecologic Practice. Depot medroxyprogesterone acetate and bone effects. Obstetrics and Gynecology2008;112:727‐30. ">ACOG 2008</a>; <a href="./references#CD006033-bbs2-0045" title="GuilbertER , BrownJP , KaunitzAM , WagnerMS , BérubéJ , CharbonneauL , et al. The use of depot‐medroxyprogesterone acetate in contraception and its potential impact on skeletal health. Contraception2009;79:167‐77. ">Guilbert 2009</a>). In guidance about medical eligibility criteria for contraceptive use, DMPA is category 1 (no restriction) for women aged 18 to 45 years (<a href="./references#CD006033-bbs2-0036" title="Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. http://www.cdc.gov/mmwr/pdf/rr/rr59e0528.pdf (accessed 23 Jan 2012):34. ">CDC 2010</a>; <a href="./references#CD006033-bbs2-0070" title="World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Fourth Edition, 2009. http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html. Geneva: World Health Organization, (accessed 05 Dec 2011):45. ">WHO 2009</a>). For women outside that age range, DMPA is category 2, meaning the advantages generally outweigh the theoretical or proven risks. </p> </section> <section id="CD006033-sec-0026"> <h4 class="title">Oral contraceptives (OCs)</h4> <p>OCs are the most commonly used reversible method in more developed countries (<a href="./references#CD006033-bbs2-0063" title="UnitedNations , Department of Economic and Social Affairs, PopulationDivision . World Contraceptive Use 2011. http://www.un.org/esa/population/publications/contraceptive2011/wallchart_front.pdf (accessed 02 May 2012). ">UN 2011</a>). Failure rates for oral contraceptives in the USA (combined and progestin‐only) are estimated at 0.3% for perfect use and 9% for typical use in the first year (<a href="./references#CD006033-bbs2-0062" title="TrussellJ . Contraceptive failure in the United States. Contraception2011;83:397‐404. ">Trussell 2011</a>). </p> <p>Few associations have been noted between OC use and fracture risk in observational studies (<a href="./references#CD006033-bbs2-0051" title="LopezLM , ChenM , MullinsS , CurtisKM , HelmerhorstFM . Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD009849.pub2] ">Lopez 2012</a>). A cohort study found OC ever‐users had increased risk for all fractures (<a href="./references#CD006033-bbs2-0038" title="CooperC , HannafordP , CroftP , KayCR . Oral contraceptive pill use and fractures in women: a prospective study. Bone1993;14(1):41‐5. ">Cooper 1993</a>). However, a case‐control study, with later data from a subset, reported no association except for those with 10 years or more since use (<a href="./references#CD006033-bbs2-0055" title="MemonS , IversenL , HannafordPC . Is the oral contraceptive pill associated with fracture in later life? New evidence from the Royal College of General Practitioners Oral Contraception Study. Contraception2011;84(1):40‐7. ">Memon 2011</a>). Another case‐control study reported increased risk, but only for those who had 10 or more prescriptions (<a href="./references#CD006033-bbs2-0054" title="MeierC , BrauchliYB , JickSS , KraenzlinME , MeierCR . Use of depot medroxyprogesterone acetate and fracture risk. Journal of Clinical Endocrinology and Metabolism. 2010/08/06 2010; Vol. 95, issue 11:4909‐16. ">Meier 2010</a>). A cohort study of postmenopausal women found no increased fracture risk for OC use after excluding women with prior fracture (<a href="./references#CD006033-bbs2-0034" title="BaradD , KooperbergC , Wactawski‐WendeJ , LiuJ , HendrixSL , WattsNB . Prior oral contraception and postmenopausal fracture: a Womens' Health Initiative observational cohort study. Fertility and Sterility2005;84:374‐83. ">Barad 2005</a>). Two other studies found little evidence of association between OC use and fracture risk. A cohort study noted increased risk for subgroups, such as those with longer use or specific intervals since use (<a href="./references#CD006033-bbs2-0066" title="VesseyM , MantJ , PainterR . Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study. Contraception1998;57:231‐5. ">Vessey 1998</a>). A case‐control study reported increased risk for any fracture only among young women with less than average use (<a href="./references#CD006033-bbs2-0067" title="VestergaardP , RejnmarkL , MosekildeL . Oral contraceptive use and risk of fracture. Contraception2006;73:571‐6. ">Vestergaard 2006</a>). </p> <p>COCs may have little effect on BMD among healthy adult women. Prospective studies have indicated that ultra‐low dose COCs, containing 20 μg ethinyl estradiol, may affect bone development in young women (<a href="./references#CD006033-bbs2-0039" title="CromerBA . Bone mineral density in adolescent and young adult women on injectable or oral contraception. Current Opinion in Obstetrics &amp; Gynecology2003;15:353‐7. ">Cromer 2003</a>). On the other hand, COCs with 30 to 40 μg ethinyl estradiol may have no negative effect and may even protect against bone loss, at least among women 30 years of age or more (<a href="./references#CD006033-bbs2-0039" title="CromerBA . Bone mineral density in adolescent and young adult women on injectable or oral contraception. Current Opinion in Obstetrics &amp; Gynecology2003;15:353‐7. ">Cromer 2003</a>). Evidence from studies of varying designs indicates that BMD may be affected by COC use in adolescent and young women but not in adult premenopausal or postmenopausal women (<a href="./references#CD006033-bbs2-0053" title="MartinsSL , CurtisKM , GlasierAF . Combined hormonal contraception and bone health: a systematic review. Contraception2006;73:445‐69. ">Martins 2006</a>; <a href="./references#CD006033-bbs2-0047" title="HerrmannM , SeibelMJ . The effects of hormonal contraceptives on bone turnover markers and bone health. Clinical Endocrinology2010;72(5):571‐83. ">Herrmann 2010</a>; <a href="./references#CD006033-bbs2-0068" title="WarholmL , PetersenK R , RavnP . Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review. Eur J Contracept Reprod Health Care2012;17:245‐53. ">Warholm 2012</a>). However, COC use may have a negative effect on bone turnover markers, although the clinical significance of such change is unclear (<a href="./references#CD006033-bbs2-0047" title="HerrmannM , SeibelMJ . The effects of hormonal contraceptives on bone turnover markers and bone health. Clinical Endocrinology2010;72(5):571‐83. ">Herrmann 2010</a>). </p> </section> <section id="CD006033-sec-0027"> <h4 class="title">Intrauterine device (IUD) or system (IUS)</h4> <p>For the levonorgestrel IUS, no mechanism is apparent that might affect bone health (<a href="./references#CD006033-bbs2-0052" title="MansourD . The benefits and risks of using a levonorgestrel‐releasing intrauterine system for contraception. Contraception2012;85(3):224‐34. ">Mansour 2012</a>). However, a case‐control study reported reduced fracture risk for ever‐use of the hormonal IUD and longer use of that IUD (<a href="./references#CD006033-bbs2-0067" title="VestergaardP , RejnmarkL , MosekildeL . Oral contraceptive use and risk of fracture. Contraception2006;73:571‐6. ">Vestergaard 2006</a>). </p> </section> </section> <section id="CD006033-sec-0028"> <h3 class="title" id="CD006033-sec-0028">Why it is important to do this review</h3> <p>Hormonal contraceptives are among the most effective and most widely‐used contraceptives. Concern about fractures may limit the use of these effective contraceptives. Women might switch to less effective methods or use nothing, potentially leading to increased rates of unintended pregnancy. The question about an association between steroidal contraceptives and fractures is important to examine systematically with the available evidence. Since our initial review in 2006, we also examined evidence of actual fracture risk in observational studies of hormonal contraceptives (<a href="./references#CD006033-bbs2-0051" title="LopezLM , ChenM , MullinsS , CurtisKM , HelmerhorstFM . Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD009849.pub2] ">Lopez 2012</a>). In this update, we further examine the effect of using steroidal contraceptives before menopause on general bone health, based on evidence from randomized controlled trials. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006033-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006033-sec-0029"></div> <p>Our aim was to evaluate the effect of using hormonal contraceptives before menopause on the risk of fracture in women. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006033-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006033-sec-0030"></div> <section id="CD006033-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006033-sec-0032"> <h4 class="title">Types of studies</h4> <p>We considered randomized controlled trials (RCTs) if they examined fractures, bone mineral density, or bone turnover in women who used hormonal contraceptives prior to menopause. </p> <p>Studies were excluded if hormones were provided for treatment of a specific condition or if the study focused on women with a certain condition, such as endometriosis, polycystic ovary disease, or hirsutism. Also excluded were studies that provided hormone replacement therapy to postmenopausal women. </p> </section> <section id="CD006033-sec-0033"> <h4 class="title">Types of participants</h4> <p>We included women in the identified trials who were randomly assigned to study groups.</p> </section> <section id="CD006033-sec-0034"> <h4 class="title">Types of interventions</h4> <p>Interventions included comparisons of a hormonal contraceptive with a placebo or with another hormonal contraceptive that differed in terms of drug, dosage, or regimen. Interventions also included the provision of a supplement, for example, another hormone or a vitamin or mineral preparation, to one group. </p> <p>We excluded interventions involving exercise, which appears to interact with hormonal contraceptives to affect bone health. </p> </section> <section id="CD006033-sec-0035"> <h4 class="title">Types of outcome measures</h4> <section id="CD006033-sec-0036"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was fractures occurring after baseline, particularly fractures of the spine, hip, and wrist. </p> </section> <section id="CD006033-sec-0037"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD006033-list-0001"> <li> <p>Bone mineral density, which could have been measured, e.g., at the femur, lumbar spine or whole body; </p> </li> <li> <p>Biochemical markers of bone turnover (<a href="./references#CD006033-bbs2-0064" title="VasikaranS , CooperC , EastellR , GriesmacherA , MorrisHA , TrentiT , et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clinical Chemistry and Laboratory Medicine2011;49(8):1271‐4. ">Vasikaran 2011a</a>; <a href="./references#CD006033-bbs2-0065" title="VasikaranS , EastellR , BruyereO , FoldesAJ , GarneroP , GriesmacherA , et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis International2011;22(2):391‐420. ">Vasikaran 2011b</a>), e.g., </p> <ul id="CD006033-list-0002"> <li> <p>bone formation ‐ serum osteocalcin, alkaline phosphatase, and type I procollagen;</p> </li> <li> <p>bone resorption ‐ serum calcium and C‐telopeptide; urinary pyridinoline and N‐telopeptides.</p> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD006033-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006033-sec-0039"> <h4 class="title">Electronic searches</h4> <p>Through April 2014, we searched the computerized databases MEDLINE, POPLINE, Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, and LILACS for studies of fracture or bone health and hormonal contraceptives. In addition, we searched for recent clinical trials through ClinicalTrials.gov and the International Clinical Trials Registry Platform (ICTRP). The strategies are given in <a href="./appendices#CD006033-sec-0076">Appendix 1</a>. Previous search strategies can be found in <a href="./appendices#CD006033-sec-0084">Appendix 2</a>. </p> </section> <section id="CD006033-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We examined reference lists of relevant articles for other trials. For the initial review, we wrote to known investigators for information about other published or unpublished trials not discovered in our search. </p> </section> </section> <section id="CD006033-sec-0041"> <h3 class="title" id="CD006033-sec-0041">Data collection and analysis</h3> <section id="CD006033-sec-0042"> <h4 class="title">Selection of studies</h4> <p>We assessed for inclusion all titles and abstracts identified during the literature searches with no language limitation. </p> </section> <section id="CD006033-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>Two authors independently abstracted the data. Data were entered into RevMan, and a second author verified accuracy. Any discrepancies were resolved by discussion. </p> </section> <section id="CD006033-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Studies were examined for methodological quality, according to the principles recommended in <a href="./references#CD006033-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. John Wiley &amp; Sons, Ltd, (accessed 30 Mar 2011). ">Higgins 2011</a>. Factors considered were study design, method for generating the randomization sequence, allocation concealment, blinding, and losses to follow up and early discontinuation. We also examined the methods used for assessing the outcomes. </p> </section> <section id="CD006033-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>None of the trials examined the same types of interventions. Therefore, we did not combine any trials in a meta‐analysis. </p> </section> <section id="CD006033-sec-0046"> <h4 class="title">Data synthesis</h4> <p>For continuous variables, the mean difference (MD) was computed with 95% confidence interval (CI) using a fixed‐effect model. RevMan uses the inverse variance approach. For dichotomous outcomes, the Mantel‐Haenszel odds ratio (OR) with 95% CI was calculated using a fixed‐effect model. </p> <p>We applied principles from GRADE to assess the evidence quality and address confidence in the effect estimates (<a href="./references#CD006033-bbs2-0033" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. ">Balshem 2011</a>). When a meta‐analysis is not viable due to varied interventions, a 'Summary of findings' table is not feasible. Therefore, we did not conduct a formal GRADE assessment with an evidence profile and 'Summary of findings' table (<a href="./references#CD006033-bbs2-0046" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>). </p> <p>For the 2011 update, we added an assessment of evidence quality using the GRADE approach (<a href="./references#CD006033-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. John Wiley &amp; Sons, Ltd, (accessed 30 Mar 2011). ">Higgins 2011</a>). This assessment was based on the quality of evidence from the individual studies. In 2014, we refined the criteria used, based on our subsequent experience with other reviews. Evidence quality could be high, moderate, low, or very low. We considered the evidence from RCTs to be high quality initially, then downgraded for each of the following: a) randomization sequence generation and allocation concealment: no information on either, or one was inadequate; b) lack of blinding; c) follow up was 12 months or less for BMD measures only; d) losses were greater than 20% for the primary analysis. </p> </section> <section id="CD006033-sec-0047"> <h4 class="title">Sensitivity analysis</h4> <p>In 2014, we added a sensitivity analysis. This included trials that provided sufficient data and evidence of moderate or high quality. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006033-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006033-sec-0048"></div> <section id="CD006033-sec-0049"> <h3 class="title">Description of studies</h3> <section id="CD006033-sec-0050"> <h4 class="title">Results of the search</h4> <p>The 2014 search produced 54 unduplicated citations from the main databases. In addition, we found seven unduplicated trials through ClinicalTrials.gov and ICTRP. Three new trials were added, including one that had been 'ongoing' in the previous update (<a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>; <a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a>; <a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a>). In addition new ongoing trial was added (<a href="./references#CD006033-bbs2-0031" title="BonnyA . Drug exposure and depot medroxyprogesterone acetate (DMPA) in adolescent subjects. http://clinicaltrials.gov/ct2/show/NCT01461824 (accessed 21 Nov 2013). [NCT01461824] ">Bonny 2013</a>). An earlier ongoing trial is still awaiting classification due to lack of a report (<a href="./references#CD006033-bbs2-0030" title="Teva Pharmaceutical Industries (Duramed Research). A multicenter study to evaluate the effects of DR‐105 on bone mineral density in adolescent females. http://clinicaltrials.gov/ct2/show/NCT00924560 (accessed 02 Jan 2014). ">Teva 2013</a>). </p> <p>We identified 19 randomized controlled trials that met the criteria for inclusion. Bone density was measured in 17 trials; the other two assessed biochemical markers of bone turnover (<a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a>; <a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a>). Twelve studies assessed BMD as well as biochemical markers. None had fracture as an outcome. Of the 17 trials that examined BMD, 14 measured the lumbar spine using dual‐energy X‐ray absorptiometry (DEXA), although the measurement site varied somewhat. The other three studies with BMD used computed tomography for the lumbar spine (<a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a>), DEXA for the arm (<a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a>), and single photon absorptiometry for the arm (<a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a>). </p> </section> <section id="CD006033-sec-0051"> <h4 class="title">Included studies</h4> <p>Most of the studies were 12 to 24 months in duration and two were 36 months long (<a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a>; <a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a>). One trial was limited to six months (<a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a>). A crossover trial had the participants switch COCs at 9 months for a total duration of 18 months (<a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>). Three studies focused on adolescents (<a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>; <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>; <a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a>). </p> <p>The types and formulations of hormonal contraceptives varied. Eleven trials compared different COCs or regimens of COCs: </p> <p> <ul id="CD006033-list-0003"> <li> <p>Two studied desogestrel‐containing COCs (<a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a>; <a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a>). </p> </li> <li> <p>Four examined levonorgestrel preparations as the investigational drug or the comparator (<a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a>; <a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a>; <a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a>; <a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a>). </p> </li> <li> <p>Three examined gestodene preparations (<a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a>; <a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a>; <a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>). </p> </li> <li> <p>Two examined drospirenone‐containing COCs (<a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a>; <a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a>). </p> </li> </ul> </p> <p>In addition, five trials examined an injectable versus another injectable, implant, or IUD (<a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a>; <a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a>; <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>; <a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a>; <a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a>), two compared two implants each (<a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a>; <a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a>), and one studied the transdermal patch versus the vaginal ring (<a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a>). </p> </section> </section> <section id="CD006033-sec-0052"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD006033-sec-0053"> <h4 class="title">Allocation</h4> <p>Study design and reporting varied in quality across these trials.</p> <p>Randomization information was as follows:</p> <p> <ul id="CD006033-list-0004"> <li> <p>Two trials had interactive voice‐response systems, based on computer‐generated random lists (<a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a>; <a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a>). </p> </li> <li> <p>Most used a random numbers table or a computer for random‐number sequence generation (<a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a>; <a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a>; <a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>; <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>; <a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a>; <a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a>; <a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a>; <a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a>; <a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a>; <a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a>; <a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a>). <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a> mentioned block randomization techniques but did not specify the block size. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a> reported randomized by 'drawing lots' without further explanation. </p> </li> <li> <p>Five studies did not provide the method for sequence generation (<a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a>; <a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a>; <a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a>; <a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a>; <a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a>). </p> </li> </ul> </p> <p>Allocation concealment was unclear in many studies and not mentioned in others. As noted above, two had an interactive voice‐response system (<a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a>; <a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a>). <a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a> reported having sealed envelopes prepared at the WHO, and <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a> communicated that they used serially‐numbered opaque envelopes. <a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a> used sealed envelopes, and <a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a> reported the sequence was concealed until treatment was assigned. Two trials did not have any concealment and 11 trials had insufficient or no information. </p> </section> <section id="CD006033-sec-0054"> <h4 class="title">Blinding</h4> <p> <ul id="CD006033-list-0005"> <li> <p>Some blinding was used in six trials: double‐blind (<a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>; <a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a>; <a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a>); investigators and providers (<a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a>); laboratory personnel (<a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a>); and participants (<a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a>). </p> </li> <li> <p>Six trials were open‐label (<a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a>; <a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a>; <a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a>; <a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a>; <a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a>; <a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a>). </p> </li> <li> <p>Information on blinding was not available from seven studies (<a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a>; <a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>; <a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a>; <a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a>; <a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a>; <a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a>; <a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a>). </p> </li> </ul> </p> </section> <section id="CD006033-sec-0055"> <h4 class="title">Incomplete outcome data</h4> <p>Losses were high in several trials, but largely due to method discontinuation or missing data. Losses greater than 20% threaten trial validity (<a href="./references#CD006033-bbs2-0061" title="StraussSE , RichardsonWS , GlasziouP , HaynesRB . Evidence‐based Medicine: How to Practice and Teach EBM. Third Edition. New York: Churchill Livingstone, 2005. ">Strauss 2005</a>). </p> <p> <ul id="CD006033-list-0006"> <li> <p>In <a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a>, loss of participants or missing data for BMD at 12 months was 48% and 79% in the two intervention groups. At 24 months, the figures were 70% and 84%. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a> losses were attributed to discontinuation or failure to obtain a bone scan within the required window: at 12 months, 62% and 68% for the two intervention groups; at 24 months, 71% and 54%. </p> </li> <li> <p>In <a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a>, loss was 52% at 36 months with 61% loss for bone data. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a> had a 29% loss due to early discontinuation. </p> </li> <li> <p>In <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>, 24% withdrew by 12 months and 43% withdrew by 24 months. This does not include those without assessments due to early study closure. </p> </li> <li> <p>Three trials had high overall losses: <a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a> (39%); <a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a> (29%); <a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a> (41%); losses to follow up were under 20%. </p> </li> </ul> </p> </section> </section> <section id="CD006033-sec-0056"> <h3 class="title" id="CD006033-sec-0056">Effects of interventions</h3> <section id="CD006033-sec-0057"> <h4 class="title">Progestin‐only methods</h4> <p>Six trials examined methods containing only the hormone progestin, including two trials of implants and four that examined the studied DMPA 150 mg. </p> <section id="CD006033-sec-0058"> <h5 class="title">Implants</h5> <p> <ul id="CD006033-list-0007"> <li> <p><a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a> examined the six‐capsule Norplant versus a similar domestic implant (manufactured in China). BMD at Ward's triangle was higher among Norplant users than domestic implant users at 12 months (mean difference (MD) 0.07; 95% CI 0.00 to 0.14, <a href="./references#CD006033-fig-0004" title="">Analysis 1.4</a>). Both types of implants had six capsules with the same amount of levonorgestrel. The groups did not differ significantly for BMD at the other locations, nor for serum and urinary measures. </p> </li> <li> <p>In <a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a>, the implants studied were a single‐rod etonogestrel‐releasing implant and a two silicone rod levonorgestrel‐releasing implant. By 18 months, the etonogestrel‐implant group had a greater percent decrease in BMD at the midshaft ulna than the two‐rod levonorgestrel group (MD ‐0.39; 95% CI ‐0.56 to ‐0.22, <a href="./references#CD006033-fig-0010" title="">Analysis 2.2</a>) and at the distal radius (MD ‐1.00; 95% CI ‐1.09 to ‐0.91, <a href="./references#CD006033-fig-0012" title="">Analysis 2.4</a>). A secondary paper reported on BMD at 36 months, but the losses to follow up by that time were large and the groups were not significantly different for BMD at the distal radius. </p> </li> </ul> </p> </section> <section id="CD006033-sec-0059"> <h5 class="title">Injectable DMPA 150 mg</h5> <p> <ul id="CD006033-list-0008"> <li> <p><a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a> randomized women to either DMPA 150 mg every 12 weeks or the levonorgestrel implant (Norplant). The DMPA group had a lower mean for alkaline phosphatase, a marker of bone formation, than the implant group at six months (MD ‐0.65; 95% CI ‐1.21 to ‐0.09, <a href="./references#CD006033-fig-0014" title="">Analysis 3.1</a>). The groups did not differ significantly for serum osteocalcin and calcium and for urinary hydroxyproline/creatinine. BMD data were shown in a figure rather than a table. By six months, BMD at the forearm reportedly increased in the levonorgestrel implant group (reported P = 0.006) and decreased insignificantly in the DMPA group. The group difference was reportedly significant at the proximal (reported P = 0.025) but not the distal forearm. </p> </li> </ul> <ul id="CD006033-list-0009"> <li> <p>Two trials examined estrogen supplement versus a placebo for women on DMPA. All participants had an injection of DMPA 150 mg every 12 weeks. </p> </li> </ul> <ul class="plain" id="CD006033-list-0010"> <li> <ul id="CD006033-list-0011"> <li> <p>In <a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>, one DMPA group received monthly injections of estradiol cypionate (E<sub>2</sub>C) 5 mg whereas the other received the placebo supplement of 5 mL normal saline solution. Bone mineral apparent density (BMAD) was used to correct for variation in bone (see <a href="./references#CD006033-sec-0102" title="">Characteristics of included studies</a>). At 12 months, the groups with the estrogen supplement had increases while the placebo‐supplement group had decreases for spine BMD (MD 2.90; 95% CI 1.80 to 4.00, <a href="./references#CD006033-fig-0018" title="">Analysis 4.1</a>), spine BMAD (MD 2.70; 95% CI 1.60 to 3.80, <a href="./references#CD006033-fig-0019" title="">Analysis 4.2</a>), and femoral neck BMD (MD 3.20; 95% CI 1.36 to 5.04, <a href="./references#CD006033-fig-0020" title="">Analysis 4.3</a>). The groups were not significantly different for femoral neck BMAD (<a href="./references#CD006033-fig-0021" title="">Analysis 4.4</a>). At 24 months, the same trend was seen: spine BMD (MD 4.60; 95% CI 2.87 to 6.33, <a href="./references#CD006033-fig-0022" title="">Analysis 4.5</a>), spine BMAD (MD 4.90; 95% CI 3.11 to 6.69, <a href="./references#CD006033-fig-0023" title="">Analysis 4.6</a>), femoral neck BMD (MD 9.80; 95% CI 4.96 to 14.64, <a href="./references#CD006033-fig-0024" title="">Analysis 4.7</a>), and femoral neck BMAD (MD 7.10; 95% CI 0.50 to 13.70, <a href="./references#CD006033-fig-0025" title="">Analysis 4.8</a>). The trial was stopped early due to the differences reaching the predetermined significance level (P &lt; 0.001). </p> </li> <li> <p><a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a> randomized DMPA users to daily intake of conjugated estrogens 62.5 μg or to a placebo supplement. BMD was measured at the lumbar spine, femoral neck, Ward's triangle, trochanter, and total body. For lumbar spine BMD, the group with the estrogen supplement had a small increase and the placebo‐supplement group had a small decrease by 12 months (MD 0.02; 95% CI 0.00 to 0.04, <a href="./references#CD006033-fig-0026" title="">Analysis 5.1</a>) and by 24 months (MD 0.04; 95% CI 0.02 to 0.06, <a href="./references#CD006033-fig-0027" title="">Analysis 5.2</a>). More than a fourth of the participants discontinued early. No significant changes were reportedly apparent in plasma calcium, phosphate, or alkaline phosphatase activity or in urinary N‐telopeptides/creatinine. </p> </li> </ul> </li> </ul> <ul id="CD006033-list-0012"> <li> <p>In <a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a>, intramuscular DMPA 150 mg/mL (DMPA‐IM) was compared with subcutaneous DMPA 104 mg/0.65 mL (DMPA‐SC). The groups did not differ significantly in the proportions with a 5% or greater decrease in total hip BMD at one, two, or three years. For lumbar spine BMD, more of the DMPA‐SC group had a 5% or greater decrease by year 3 (OR 2.11; 95% CI 1.00 to 4.45, <a href="./references#CD006033-fig-0041" title="">Analysis 6.6</a>). Losses due to discontinuation were high. </p> </li> </ul> </p> </section> </section> <section id="CD006033-sec-0060"> <h4 class="title">Combination contraceptives</h4> <p>These 13 trials included 11 that compared combined oral contraceptives, as well as one of a combination injectable versus a non‐hormonal IUD and one of the transdermal patch versus the vaginal ring. </p> <section id="CD006033-sec-0061"> <h5 class="title">Oral contraceptives</h5> <p>Two compared desogestrel‐containing COCs versus other COCs:</p> <p> <ul id="CD006033-list-0013"> <li> <p><a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a> randomized women to norethindrone 1 mg plus ethinyl estradiol (EE) 35 μg or to desogestrel 150 μg plus EE 30 μg. The norethindrone group had a significantly greater increase in BMD at the lumbar spine at 12 months than the desogestrel group (MD 1.83; 95% CI 0.42 to 3.24, <a href="./references#CD006033-fig-0042" title="">Analysis 7.1</a>). By 24 months, both groups had decreases from baseline but they were not significantly different. However, only about one‐third of the original participants remained at 12 months. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a> also used desogestrel 150 μg plus EE 30 μg, but the comparison was cyproterone acetate (CPA) 2 mg plus EE 35 μg. The group with the desogestrel‐containing COC did not differ significantly from the CPA group for the BMD measures of lumbar spine or femoral neck at 12 or 24 months (<a href="./references#CD006033-fig-0044" title="">Analysis 8.1</a> to <a href="./references#CD006033-fig-0047" title="">Analysis 8.4</a>). </p> </li> </ul> </p> <p>Four trials used preparations containing levonorgestrel, either as the investigational drug or the comparator: </p> <p> <ul id="CD006033-list-0014"> <li> <p><a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a> compared levonorgestrel 100 μg plus 20 EE μg versus levonorgestrel 150 μg plus EE 30 μg. The two groups did not differ significantly in their slight decreases in BMD at 36 months (<a href="./references#CD006033-fig-0048" title="">Analysis 9.1</a> to <a href="./references#CD006033-fig-0051" title="">Analysis 9.4</a>). Serum alkaline phosphatase increased and N‐telopeptides decreased, but change did not differ significantly between the groups. More than half of the participants were lost to follow up. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a> examined levonorgestrel 100 μg plus 20 EE μg versus desogestrel 150 μg plus EE 20 μg. By 12 months, the desogestrel group lost more areal BMD at the lumbar spine than the levonorgestrel group, but the difference was small (MD 1.41; 95% CI ‐0.11 to 2.93, <a href="./references#CD006033-fig-0054" title="">Analysis 10.1</a>). The desogestrel group had a greater decrease in serum alkaline phosphatase (MD 15.31; 95% CI 3.91 to 26.71, <a href="./references#CD006033-fig-0056" title="">Analysis 10.3</a>). The groups did not differ significantly in change in areal BMD at the femoral neck or in serum osteocalcin or C‐telopeptides (<a href="./references#CD006033-fig-0055" title="">Analysis 10.2</a>; <a href="./references#CD006033-fig-0057" title="">Analysis 10.4</a>; <a href="./references#CD006033-fig-0058" title="">Analysis 10.5</a>). </p> </li> <li> <p><a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a> compared a continuous regimen of levonorgestrel 90 μg plus EE 20 μg versus a cyclic regimen of levonorgestrel 100 μg plus EE 20 μg. The report provided standard errors and did not contain cell sizes, so we could not analyze any data. Reportedly, changes in osteocalcin and C‐telopeptides were not significantly different between the groups by cycle 13. </p> </li> <li> <p>For <a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a>, the COC of interest was nomegestrol 2.5 mg plus [17ß] estradiol 1.5 mg (NOMAC‐E2), and the comparison was levonorgestrel 150 μg plus EE 30 μg. By cycle 26, the groups did not differ significantly for change in z‐score of the lumbar spine (<a href="./references#CD006033-fig-0059" title="">Analysis 11.1</a>) or femoral neck (<a href="./references#CD006033-fig-0060" title="">Analysis 11.2</a>). </p> </li> </ul> </p> <p>Gestodene‐containing COCs were the focus of three trials:</p> <p> <ul id="CD006033-list-0015"> <li> <p><a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a> randomized women to gestodene 75 μg plus EE 20 μg or gestodene 75 μg plus EE 30 μg. At 12 months, urinary deoxypyridinoline was lower in the EE 30 μg group than in the EE 20 μg group (MD 1.20; 95% CI 0.37 to 2.03, <a href="./references#CD006033-fig-0062" title="">Analysis 12.2</a>). The study groups were not significantly different for serum osteocalcin and urinary pyridinoline. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a> studied gestodene 75 μg plus EE 20 μg versus gestodene 60 μg plus EE 15 μg. The results were presented in figures without absolute values. The investigators reported no significant difference at 12 months between or within the groups in BMD at the lumbar spine or in serum osteocalcin. The study groups reportedly had significant declines in urinary pyridinoline and deoxypyridinoline by 6 and 12 months (reported P &lt; 0.05), but the groups did not differ significantly. </p> </li> <li> <p>The crossover study of <a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a> compared gestodene 75 μg plus EE 30 μg versus gestodene 60 μg plus EE 15 μg. The participants were switched to the other formulation at nine months; study duration was 18 months. Measures included BMD of the lumbar spine, femur, and distal radius, as well as serum type I procollagen (PINP) and type I collagen cross‐linked C‐telopeptide (ßCTX1). The report included results of the full analysis of variance model (ANOVA) for lumbar BMD, PINP, and ßCTX1 (<a href="#CD006033-tbl-0001">Table 3</a>). Reportedly, dose was significantly associated with change in lumbar BMD (reported F‐ratio = 4.6; reported P value = 0.037). The COC containing EE 30 μg showed an increase while the COC containing EE 15 μg showed a decrease. Dose was also reportedly associated with a difference in PINP (reported F‐ratio = 8.3; reported P value = 0.005), but the text and figure were inconsistent regarding the direction of change. For ßCTX1, no significant difference was reported. </p> </li> </ul> </p> <div class="table" id="CD006033-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcomes by 18 months (Cibula 2012)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome at 18 months (crossover at 9 months)<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Variable<sup>2</sup> </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reported<br/> F‐ratio</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reported<br/> P value</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in lumbar spine BMD (g/cm<sup>2</sup>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dose</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.037</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in propeptide of type I procollagen (μg/l)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dose</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.005</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in cross‐linked telopeptide (μg/l)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dose</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.397</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>From full ANOVA model for crossover design; reportedly adjusted for intraindividual variability, sequence of treatment, period of trial, initial value of outcome measure, age, and smoking. Report did not mention ANOVA for the other BMD measures.<br/> <sup>2</sup>Gestodene 75 μg plus EE 30 μg versus gestodene 60 μg plus EE 15 μg; participants were switched to the other formulation at 9 months </p> </div> </div> <p>Drospirenone‐containing COCs were examined in two trials:</p> <p> <ul id="CD006033-list-0016"> <li> <p><a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a> examined drospirenone 3 mg plus EE 30 μg versus gestodene 75 μg plus EE 30 μg. Bone mineral density at the lumbar spine did not differ significantly between the two groups at 12 months (<a href="./references#CD006033-fig-0064" title="">Analysis 13.1</a>). Data for biochemical markers were presented in figures without absolute numbers. Reportedly, the groups did not differ significantly for urinary pyridinoline or deoxypyridinoline but both groups decreased significantly. Serum calcium reportedly increased significantly in the drospirenone‐COC group and was significantly different from that gestodene‐COC group. Reportedly, other changes in serum and urinary calcium were not significant. The investigators also reported that serum osteocalcin did not change significantly; within‐group changes were not mentioned. </p> </li> <li> <p><a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a> compared drospirenone 3 mg plus EE 30 μg versus drospirenone 3 mg plus EE 20 μg. BMD at the lumbar spine did not differ significantly between the two groups at 12 months (<a href="./references#CD006033-fig-0065" title="">Analysis 14.1</a>). Biochemical measures were shown in figures without absolute numbers. The investigators reported the study groups were not significantly different at 12 months for urinary pyridinoline and deoxypyridinoline but that both groups decreased significantly. They also reported that no significant difference between groups for serum or urinary calcium or for serum osteocalcin. Reportedly, both groups had significant increases in serum calcium but changes within group were not significant for the other measures. </p> </li> </ul> </p> </section> <section id="CD006033-sec-0062"> <h5 class="title">Injectable versus non‐hormonal IUD</h5> <p><a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a> compared monthly injections of norethisterone enanthate 50 mg plus estradiol valerate (E<sub>2</sub>V) 5 mg versus the Nova‐T IUD. Bone density did not differ significantly between the injectable group and the IUD group at 24 months (<a href="./references#CD006033-fig-0070" title="">Analysis 16.1</a>, <a href="./references#CD006033-fig-0071" title="">Analysis 16.2</a>). The trial focused on serum lipid patterns; bone density was of secondary interest. Only half the women were assigned to have bone density measures, and many did not have outcome data. Changes in BMD were modest but positive. However, the analyzed groups were so small due to high losses that the results may not be meaningful. </p> </section> <section id="CD006033-sec-0063"> <h5 class="title">Patch versus ring</h5> <p><a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a> compared the contraceptive patch delivering norelgestromin 150 μg plus EE 20 μg daily versus the vaginal ring releasing etonogestrel 120 μg plus EE 15 μg daily. At 12 months, the study groups did not differ significantly in spinal BMD, urinary pyridinoline, urinary deoxypyridinoline, and serum osteocalcin (<a href="./references#CD006033-fig-0066" title="">Analysis 15.1</a> to <a href="./references#CD006033-fig-0069" title="">Analysis 15.4</a>). Spinal BMD did not change much from baseline, while the biochemical markers generally had changes that were positive for bone health. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006033-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006033-sec-0064"></div> <section id="CD006033-sec-0065"> <h3 class="title" id="CD006033-sec-0065">Summary of main results</h3> <p>We summarized the results by contraceptive method and composition (<a href="#CD006033-tbl-0002">Table 4</a>). Two studies of DMPA plus a supplement were placebo‐controlled, and one study compared a combination injectable to a non‐hormonal IUD. Since the estrogen preparations and routes of administration differed for the DMPA trials, we did not conduct a meta‐analysis. Nonetheless, the two trials showed BMD increases for the women who received DMPA plus estrogen supplement and decreases for those who had DMPA plus placebo supplement. In the combination injectable study, BMD changes were modest but the losses were too high for results to be informative. </p> <div class="table" id="CD006033-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Summary of outcome data</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison groups</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bone mineral<br/> density:<br/> # differences/<br/> # measures<sup>1</sup> </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biochemical<br/> markers:<br/> # differences/<br/> # measures</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Progestin‐only contraceptives</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Implants </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 6‐rod (standard) vs</p> <p>levonorgestrel 6‐rod (domestic)</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>etonogestrel 1‐rod vs</p> <p>levonorgestrel 2‐rod</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/5</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Injectable DMPA </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA vs</p> <p>levonorgestrel 6‐rod implant</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + E<sub>2</sub>C vs </p> <p>DMPA + placebo</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/8</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + conjugated estrogens 62.5 μg vs</p> <p>DMPA + placebo</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/10</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA subcutaneous vs</p> <p>DMPA intramuscular</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Combination contraceptives</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Oral contraceptives </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethindrone 1 mg + EE 35 μg vs</p> <p>desogestrel 150 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>desogestrel 150 μg + EE 30 μg vs</p> <p>cyproterone acetate 2 mg + EE 35 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 100 μg + EE 20 μg vs</p> <p>levonorgestrel 150 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 100 μg + EE 20 μg vs</p> <p>desogestrel 150 μg + EE 20 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 90 μg + EE 20 μg (continuous) vs</p> <p>levonorgestrel 100 μg + EE 20 μg (cyclic)</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nomegestrol 2.5 mg + 17ß estradiol 1.5 mg vs</p> <p>levonorgestrel 150 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 30 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>drospirenone 3 mg + EE 30 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>drospirenone 3 mg + EE 30 vs</p> <p>drospirenone 3 mg + EE 20</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Injectable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethisterone enanthate + E<sub>2</sub>V vs </p> <p>Nova‐T IUD</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Patch versus ring </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>transdermal patch vs</p> <p>vaginal ring</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/3</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>Number of significant differences between study group divided by number of outcome measures (e.g., lumbar spine, femoral neck). </p> </div> </div> <p>Most trials compared two different hormonal contraceptives. Combination oral contraceptives did not appear to negatively affect bone density, and some formulations had more positive effects than others. However, none were placebo‐controlled. Where trials showed differences between groups in biochemical markers of bone formation, the results were generally consistent with those for bone mineral density. For the progestin‐only implants, two trials studied different implants, used different sites for measuring BMD, and had varying durations. One study showed a greater decrease in BMD for the etonogestrel‐implant group than the two‐rod levonorgestrel group. </p> <section id="CD006033-sec-0066"> <h4 class="title">Sensitivity analysis</h4> <p>We assessed the quality of the evidence, as discussed below (<a href="#CD006033-tbl-0019">Table 1</a>). Our sensitivity analysis had 11 trials that provided sufficient data for the outcome and evidence of moderate or high quality (<a href="#CD006033-tbl-0020">Table 2</a>). These included the four DMPA studies, the two implant trials, the combination injectable and patch versus study, but only 3 of the 11 COC trials. The results were similar to those for the review overall. Of the four DMPA‐IM trials, two showed a positive effect of an estrogen supplement on BMD, one had a negative effect of DMPA‐SC on lumbar spine BMD, and the fourth indicated a negative effect of DMPA‐IM on a bone formation marker. The two implant studies each had one significant difference in BMD out of several measures. Of the three COC trials, two examined BMD, of which one showed a decrease for the group with gestodene plus EE 15 μg. Of the two that used biochemical measures, one indicated less bone resorption in the group with gestodene plus EE 30 μg versus EE 20 μg. No significant differences were noted in the trials of the combination injectable or the patch versus ring. </p> </section> </section> <section id="CD006033-sec-0067"> <h3 class="title" id="CD006033-sec-0067">Overall completeness and applicability of evidence</h3> <p>None of the studies included fracture as an outcome. Longer follow up would be needed for meaningful assessment of fracture. Since fragility fractures are rare in young people, fracture is not usually an outcome in studies of premenopausal bone health (<a href="./references#CD006033-bbs2-0043" title="GourlayML , BrownSA . Clinical considerations in premenopausal osteoporosis. Archives of Internal Medicine2004;164:603‐14. ">Gourlay 2004</a>). Researchers and clinicians may have to rely on bone mineral density and biochemical measures of bone health. BMD correlates with fracture but is not a valid surrogate endpoint for fracture (<a href="./references#CD006033-bbs2-0044" title="GrimesDA , SchulzKF , RaymondEG . Surrogate end points in women's health research: science, protoscience, and pseudoscience. Fertility and Sterility2010;93(6):1731‐4. ">Grimes 2010</a>). BMD is considered useful in screening for osteoporosis in postmenopausal women. However, its validity in assessing risk is still unclear for premenopausal women, including those using steroidal contraceptives (<a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). International organizations have recommended using bone turnover markers rather than BMD for monitoring treatment of osteoporosis (<a href="./references#CD006033-bbs2-0064" title="VasikaranS , CooperC , EastellR , GriesmacherA , MorrisHA , TrentiT , et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clinical Chemistry and Laboratory Medicine2011;49(8):1271‐4. ">Vasikaran 2011a</a>). In this review, markers of bone formation included serum alkaline phosphatase, osteocalcin, and type I procollagen; bone resorption indicators included serum calcium and C‐telopeptide as well as urinary pyridinoline and N‐telopeptides. Recommended reference markers are serum procollagen type I N propeptide, s‐PINP (bone formation); and serum C‐terminal cross‐linking telopeptide of type I collagen, s‐CTX (bone resorption) (<a href="./references#CD006033-bbs2-0064" title="VasikaranS , CooperC , EastellR , GriesmacherA , MorrisHA , TrentiT , et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clinical Chemistry and Laboratory Medicine2011;49(8):1271‐4. ">Vasikaran 2011a</a>; <a href="./references#CD006033-bbs2-0065" title="VasikaranS , EastellR , BruyereO , FoldesAJ , GarneroP , GriesmacherA , et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis International2011;22(2):391‐420. ">Vasikaran 2011b</a>). Decreases in these markers correlate better than others with reduction in fracture risk. However, the relationship of hormonal contraceptive use and bone health is less well understood (<a href="./references#CD006033-bbs2-0047" title="HerrmannM , SeibelMJ . The effects of hormonal contraceptives on bone turnover markers and bone health. Clinical Endocrinology2010;72(5):571‐83. ">Herrmann 2010</a>). </p> <p>Methodological differences limited the analysis and interpretation of the data. Due to the differing interventions studied, no trials were combined for meta‐analysis. Studies compared COCs with different formulations, two types of implants, injectables with other methods, and the skin patch with the vaginal ring. Such differences in treatments limit the conclusions about any one contraceptive method. </p> <p>Of 19 studies, only 3 were limited to adolescents (<a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a>; <a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>; <a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a>); a fourth focused on young women (<a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a>). Three of those four trials showed some differences between study groups in BMD or bone turnover markers, compared to 7 of the 15 studies with older women. Adolescents are rapidly acquiring bone mass (<a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a>; <a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). Whether COCs affect the development of peak bone mass is unclear, though COCs with less than 30 μg EE may be a concern (<a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). DMPA may affect BMD in adolescents, but some studies have indicated a return to baseline after discontinuation (<a href="./references#CD006033-bbs2-0050" title="KaunitzA M , GrimesD A . Removing the black box warning for depot medroxyprogesterone acetate. Contraception2011;84:212‐3. ">Kaunitz 2011</a>; <a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). More studies focused on adolescents and younger women would be useful. However, placebo‐controlled trials in contraception are limited for ethical reasons, especially among a population at high risk for unplanned pregnancy. </p> </section> <section id="CD006033-sec-0068"> <h3 class="title" id="CD006033-sec-0068">Quality of the evidence</h3> <p>As noted earlier, we refined our criteria to identify the specific risk of bias issues in 2014 (<a href="#CD006033-sec-0044">Assessment of risk of bias in included studies</a>). For this review, the evidence quality was considered moderate overall (<a href="#CD006033-tbl-0019">Table 1</a>). The DMPA studies provided moderate quality evidence. The quality of the COC evidence varied widely, but was considered low overall. The quality was moderate to high for the studies of implants, combination injectable, and patch versus ring. </p> <p>Limitations of these studies include incomplete or no description of sequence generation and allocation concealment, lack of blinding, and high losses. Some reports did not have sufficient data for assessment; outcomes were presented in tables without absolute numbers. For losses, we could not always distinguish between losses to follow up or discontinuation. Therefore, we included all losses in our assessment. About half of the trials had high losses, so the results may not represent randomized comparisons. As noted earlier, losses greater than 20% can bias the results and threaten trial validity (<a href="./references#CD006033-bbs2-0061" title="StraussSE , RichardsonWS , GlasziouP , HaynesRB . Evidence‐based Medicine: How to Practice and Teach EBM. Third Edition. New York: Churchill Livingstone, 2005. ">Strauss 2005</a>). At least three trials lost more than half the participants and some had differential losses between the comparison groups. </p> </section> <section id="CD006033-sec-0069"> <h3 class="title" id="CD006033-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p>A review of observational studies did not indicate an overall association between OC use and fracture risk, except for some increased risk among specific user subgroups (<a href="./references#CD006033-bbs2-0051" title="LopezLM , ChenM , MullinsS , CurtisKM , HelmerhorstFM . Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD009849.pub2] ">Lopez 2012</a>). As noted earlier, COCs may have little effect on BMD among healthy adult women (<a href="./references#CD006033-bbs2-0047" title="HerrmannM , SeibelMJ . The effects of hormonal contraceptives on bone turnover markers and bone health. Clinical Endocrinology2010;72(5):571‐83. ">Herrmann 2010</a>; <a href="./references#CD006033-bbs2-0068" title="WarholmL , PetersenK R , RavnP . Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review. Eur J Contracept Reprod Health Care2012;17:245‐53. ">Warholm 2012</a>). BMD in adolescent and young women may be affected by the use of COCs with lower estrogen doses, i.e., 20 μg (<a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). COC use may have a negative effect on bone turnover markers, although the clinical significance of such change is unclear (<a href="./references#CD006033-bbs2-0047" title="HerrmannM , SeibelMJ . The effects of hormonal contraceptives on bone turnover markers and bone health. Clinical Endocrinology2010;72(5):571‐83. ">Herrmann 2010</a>). </p> <p>Of progestin‐only methods, DMPA has been associated with decreased bone mineral density (<a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). However, no published RCT has linked DMPA use with fracture later in life. A review of observational studies had two case‐control studies in the sensitivity analysis that examined DMPA (<a href="./references#CD006033-bbs2-0051" title="LopezLM , ChenM , MullinsS , CurtisKM , HelmerhorstFM . Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD009849.pub2] ">Lopez 2012</a>). One of the studies reported increased fracture risk for DMPA ever‐use, more than four years of use, and women over 50 years of age. The other noted increased risk for any past DMPA use and for current use of 3 or more prescriptions. A loss of BMD during adolescence may be recovered after discontinuing DMPA (<a href="./references#CD006033-bbs2-0050" title="KaunitzA M , GrimesD A . Removing the black box warning for depot medroxyprogesterone acetate. Contraception2011;84:212‐3. ">Kaunitz 2011</a>; <a href="./references#CD006033-bbs2-0056" title="NappiC , BifulcoG , TommaselliG A , GarganoV , DiCarloC . Hormonal contraception and bone metabolism: a systematic review. Contraception2012;86:606‐21. ">Nappi 2012</a>). The changes may be transient like those occurring during pregnancy or lactation (<a href="./references#CD006033-bbs2-0032" title="Committee on Adolescent Health, Committee on Gynecologic Practice. Depot medroxyprogesterone acetate and bone effects. Obstetrics and Gynecology2008;112:727‐30. ">ACOG 2008</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006033-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 1 Bone mineral density (L2 to L4) at 12 months." data-id="CD006033-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 1 Bone mineral density (L2 to L4) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 2 Bone mineral density (femoral neck) at 12 months." data-id="CD006033-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 2 Bone mineral density (femoral neck) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 3 Bone mineral density (trochanter) at 12 months." data-id="CD006033-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 3 Bone mineral density (trochanter) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 4 Bone mineral density (Ward's triangle) at 12 months." data-id="CD006033-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 4 Bone mineral density (Ward's triangle) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 5 Serum osteocalcin at 12 months." data-id="CD006033-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 5 Serum osteocalcin at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 6 Serum alkaline phosphatase at 12 months." data-id="CD006033-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 6 Serum alkaline phosphatase at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 7 Urine hydroxyproline/creatinine at 12 months." data-id="CD006033-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 7 Urine hydroxyproline/creatinine at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 8 Urine calcium/creatinine at 12 months." data-id="CD006033-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Levonorgestrel‐releasing implants: Norplant versus Chinese implant, Outcome 8 Urine calcium/creatinine at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 1 Bone mineral density (midshaft ulna) at 18 months." data-id="CD006033-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 1 Bone mineral density (midshaft ulna) at 18 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 2 Percent change in bone mineral density (midshaft ulna) by 18 months." data-id="CD006033-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 2 Percent change in bone mineral density (midshaft ulna) by 18 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 3 Bone mineral density (distal radius) at 18 months." data-id="CD006033-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 3 Bone mineral density (distal radius) at 18 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 4 Percent change in bone mineral density (distal radius) by 18 months." data-id="CD006033-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 4 Percent change in bone mineral density (distal radius) by 18 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 5 Bone mineral density (distal radius) at 36 months." data-id="CD006033-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant, Outcome 5 Bone mineral density (distal radius) at 36 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 1 Serum alkaline phosphatase at 6 months." data-id="CD006033-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 1 Serum alkaline phosphatase at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 2 Serum osteocalcin at 6 months." data-id="CD006033-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 2 Serum osteocalcin at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 3 Serum calcium at 6 months." data-id="CD006033-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 3 Serum calcium at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 4 Urinary hydroxyproline/creatinine at 6 months." data-id="CD006033-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 DMPA 150 mg versus levonorgestrel‐releasing implant, Outcome 4 Urinary hydroxyproline/creatinine at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 1 Percent change in bone mineral density (spine) by 12 months." data-id="CD006033-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 1 Percent change in bone mineral density (spine) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 2 Percent change in bone mineral apparent density (spine) by 12 months." data-id="CD006033-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 2 Percent change in bone mineral apparent density (spine) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 3 Percent change in bone mineral density (femoral neck) by 12 months." data-id="CD006033-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 3 Percent change in bone mineral density (femoral neck) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 4 Percent change in bone mineral apparent density (femoral neck) by 12 months." data-id="CD006033-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 4 Percent change in bone mineral apparent density (femoral neck) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 5 Percent change in bone mineral density (spine) by 24 months." data-id="CD006033-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 5 Percent change in bone mineral density (spine) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 6 Percent change in bone mineral apparent density (spine) by 24 months." data-id="CD006033-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 6 Percent change in bone mineral apparent density (spine) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 7 Percent change in bone mineral density (femoral neck) by 24 months." data-id="CD006033-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 7 Percent change in bone mineral density (femoral neck) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 8 Percent change in bone mineral apparent density (femoral neck) by 24 months." data-id="CD006033-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo, Outcome 8 Percent change in bone mineral apparent density (femoral neck) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 1 Change in bone mineral density (lumbar spine) by 12 months." data-id="CD006033-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 1 Change in bone mineral density (lumbar spine) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 2 Change in bone mineral density (lumbar spine) by 24 months." data-id="CD006033-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 2 Change in bone mineral density (lumbar spine) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 3 Change in bone mineral density (Ward's triangle) by 12 months." data-id="CD006033-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 3 Change in bone mineral density (Ward's triangle) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 4 Change in bone mineral density (Ward's triangle) by 24 months." data-id="CD006033-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 4 Change in bone mineral density (Ward's triangle) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 5 Change in bone mineral density (trochanter) by 12 months." data-id="CD006033-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 5 Change in bone mineral density (trochanter) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 6 Change in bone mineral density (trochanter) by 24 months." data-id="CD006033-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 6 Change in bone mineral density (trochanter) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 7 Change in bone mineral density (femoral neck) by 12 months." data-id="CD006033-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 7 Change in bone mineral density (femoral neck) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 8 Change in bone mineral density (femoral neck) by 24 months." data-id="CD006033-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 8 Change in bone mineral density (femoral neck) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 9 Change in bone mineral density (total body) by12 months." data-id="CD006033-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 9 Change in bone mineral density (total body) by12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 10 Change in bone mineral density (total body) by 24 months." data-id="CD006033-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo, Outcome 10 Change in bone mineral density (total body) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 1 Decrease in total hip BMD &gt;= 5% from baseline (year 1)." data-id="CD006033-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 1 Decrease in total hip BMD &gt;= 5% from baseline (year 1). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 2 Decrease in total hip BMD &gt;= 5% from baseline (year 2)." data-id="CD006033-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 2 Decrease in total hip BMD &gt;= 5% from baseline (year 2). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 3 Decrease in total hip BMD &gt;= 5% from baseline (year 3)." data-id="CD006033-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 3 Decrease in total hip BMD &gt;= 5% from baseline (year 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 4 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 1)." data-id="CD006033-fig-0039" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 4 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 1). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 5 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 2)." data-id="CD006033-fig-0040" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 5 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 2). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 6 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 3)." data-id="CD006033-fig-0041" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 DMPA‐SC 104 mg versus DMPA‐IM 150 mg, Outcome 6 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Norethindrone 1 mg + EE 35 µg versus desogestrel 150 µg + EE 30 µg, Outcome 1 Percent change in bone mineral density (lumbar spine) by 12 months." data-id="CD006033-fig-0042" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Norethindrone 1 mg + EE 35 µg versus desogestrel 150 µg + EE 30 µg, Outcome 1 Percent change in bone mineral density (lumbar spine) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Norethindrone 1 mg + EE 35 µg versus desogestrel 150 µg + EE 30 µg, Outcome 2 Percent change in bone mineral density (lumbar spine) by 24 months." data-id="CD006033-fig-0043" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Norethindrone 1 mg + EE 35 µg versus desogestrel 150 µg + EE 30 µg, Outcome 2 Percent change in bone mineral density (lumbar spine) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 1 Change in BMD of lumbar spine by 12 months." data-id="CD006033-fig-0044" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 1 Change in BMD of lumbar spine by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 2 Change in BMD of lumbar spine by 24 months." data-id="CD006033-fig-0045" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 2 Change in BMD of lumbar spine by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 3 Change in BMD of femoral neck by 12 months." data-id="CD006033-fig-0046" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 3 Change in BMD of femoral neck by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 4 Change in BMD of femoral neck by 24 months." data-id="CD006033-fig-0047" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg, Outcome 4 Change in BMD of femoral neck by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 1 Bone mineral density (lumbar spine) at 12 months." data-id="CD006033-fig-0048" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 1 Bone mineral density (lumbar spine) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 2 Bone mineral density (lumbar spine) at 24 months." data-id="CD006033-fig-0049" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 2 Bone mineral density (lumbar spine) at 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 3 Bone mineral density (lumbar spine) at 36 months." data-id="CD006033-fig-0050" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 3 Bone mineral density (lumbar spine) at 36 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 4 Percent change in bone mineral density (lumbar spine) by 36 months." data-id="CD006033-fig-0051" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 4 Percent change in bone mineral density (lumbar spine) by 36 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 5 Percent change in serum alkaline phosphatase (36 months)." data-id="CD006033-fig-0052" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 5 Percent change in serum alkaline phosphatase (36 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 6 Percent change in cross‐linked N‐telopeptides (36 months)." data-id="CD006033-fig-0053" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg, Outcome 6 Percent change in cross‐linked N‐telopeptides (36 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 1 Percent change in areal bone mineral density (lumbar spine) by 12 months." data-id="CD006033-fig-0054" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 1 Percent change in areal bone mineral density (lumbar spine) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 2 Percent change in areal bone mineral density (femoral neck) by 12 months." data-id="CD006033-fig-0055" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 2 Percent change in areal bone mineral density (femoral neck) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 3 Percent change in serum bone‐specific alkaline phosphatase by 12 months." data-id="CD006033-fig-0056" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 3 Percent change in serum bone‐specific alkaline phosphatase by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 4 Percent change in serum osteocalcin by 12 months." data-id="CD006033-fig-0057" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 4 Percent change in serum osteocalcin by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 5 Percent change in serum cross‐linked telopeptides by 12 months." data-id="CD006033-fig-0058" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg, Outcome 5 Percent change in serum cross‐linked telopeptides by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Nomegestrol 2.5 mg + estradiol 1.5 mg versus levonorgestrel 150 µg + EE 30 µg, Outcome 1 Change in z‐score of lumbar spine after cycle 26." data-id="CD006033-fig-0059" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Nomegestrol 2.5 mg + estradiol 1.5 mg versus levonorgestrel 150 µg + EE 30 µg, Outcome 1 Change in z‐score of lumbar spine after cycle 26. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Nomegestrol 2.5 mg + estradiol 1.5 mg versus levonorgestrel 150 µg + EE 30 µg, Outcome 2 Change in z‐score of femoral neck after cycle 26." data-id="CD006033-fig-0060" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Nomegestrol 2.5 mg + estradiol 1.5 mg versus levonorgestrel 150 µg + EE 30 µg, Outcome 2 Change in z‐score of femoral neck after cycle 26. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg, Outcome 1 Urinary pyridinoline at 12 months." data-id="CD006033-fig-0061" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg, Outcome 1 Urinary pyridinoline at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg, Outcome 2 Urinary deoxypyridinoline at 12 months." data-id="CD006033-fig-0062" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg, Outcome 2 Urinary deoxypyridinoline at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg, Outcome 3 Serum osteocalcin at 12 months." data-id="CD006033-fig-0063" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg, Outcome 3 Serum osteocalcin at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Drospirenone 3 mg + EE 30 µg versus gestodene 75 µg + EE 30 µg, Outcome 1 Bone mineral density (lumbar spine) at 12 months." data-id="CD006033-fig-0064" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Drospirenone 3 mg + EE 30 µg versus gestodene 75 µg + EE 30 µg, Outcome 1 Bone mineral density (lumbar spine) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Drospirenone 3 mg + EE 30 µg versus drospirenone 3 mg + EE 20 µg, Outcome 1 Bone mineral density (lumbar spine) at 12 months." data-id="CD006033-fig-0065" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Drospirenone 3 mg + EE 30 µg versus drospirenone 3 mg + EE 20 µg, Outcome 1 Bone mineral density (lumbar spine) at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 1 Lumbar spine BMD at 12 months." data-id="CD006033-fig-0066" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 1 Lumbar spine BMD at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 2 Urinary pyridinoline at 12 months." data-id="CD006033-fig-0067" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 2 Urinary pyridinoline at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 3 Urinary deoxypyridinoline at 12 months." data-id="CD006033-fig-0068" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 3 Urinary deoxypyridinoline at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 4 Serum osteocalcin at 12 months." data-id="CD006033-fig-0069" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg), Outcome 4 Serum osteocalcin at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Norethisterone enanthate 50 mg + estradiol valerate 5 mg versus Nova T IUD, Outcome 1 Percent change in bone mineral density (lumbar spine) by 12 months." data-id="CD006033-fig-0070" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Norethisterone enanthate 50 mg + estradiol valerate 5 mg versus Nova T IUD, Outcome 1 Percent change in bone mineral density (lumbar spine) by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006033-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/urn:x-wiley:14651858:media:CD006033:CD006033-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_t/tCD006033-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Norethisterone enanthate 50 mg + estradiol valerate 5 mg versus Nova T IUD, Outcome 2 Percent change in bone mineral density (lumbar spine) by 24 months." data-id="CD006033-fig-0071" src="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Norethisterone enanthate 50 mg + estradiol valerate 5 mg versus Nova T IUD, Outcome 2 Percent change in bone mineral density (lumbar spine) by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/media/CDSR/CD006033/image_n/nCD006033-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD006033-tbl-0001"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcomes by 18 months (Cibula 2012)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome at 18 months (crossover at 9 months)<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Variable<sup>2</sup> </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reported<br/> F‐ratio</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reported<br/> P value</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in lumbar spine BMD (g/cm<sup>2</sup>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dose</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.037</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in propeptide of type I procollagen (μg/l)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dose</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.005</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in cross‐linked telopeptide (μg/l)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dose</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.397</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup>From full ANOVA model for crossover design; reportedly adjusted for intraindividual variability, sequence of treatment, period of trial, initial value of outcome measure, age, and smoking. Report did not mention ANOVA for the other BMD measures.<br/> <sup>2</sup>Gestodene 75 μg plus EE 30 μg versus gestodene 60 μg plus EE 15 μg; participants were switched to the other formulation at 9 months </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcomes by 18 months (Cibula 2012)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006033-tbl-0002"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Summary of outcome data</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison groups</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bone mineral<br/> density:<br/> # differences/<br/> # measures<sup>1</sup> </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biochemical<br/> markers:<br/> # differences/<br/> # measures</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Progestin‐only contraceptives</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Implants </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 6‐rod (standard) vs</p> <p>levonorgestrel 6‐rod (domestic)</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>etonogestrel 1‐rod vs</p> <p>levonorgestrel 2‐rod</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/5</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Injectable DMPA </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA vs</p> <p>levonorgestrel 6‐rod implant</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + E<sub>2</sub>C vs </p> <p>DMPA + placebo</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/8</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + conjugated estrogens 62.5 μg vs</p> <p>DMPA + placebo</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/10</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA subcutaneous vs</p> <p>DMPA intramuscular</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Combination contraceptives</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Oral contraceptives </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethindrone 1 mg + EE 35 μg vs</p> <p>desogestrel 150 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>desogestrel 150 μg + EE 30 μg vs</p> <p>cyproterone acetate 2 mg + EE 35 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 100 μg + EE 20 μg vs</p> <p>levonorgestrel 150 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 100 μg + EE 20 μg vs</p> <p>desogestrel 150 μg + EE 20 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 90 μg + EE 20 μg (continuous) vs</p> <p>levonorgestrel 100 μg + EE 20 μg (cyclic)</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nomegestrol 2.5 mg + 17ß estradiol 1.5 mg vs</p> <p>levonorgestrel 150 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 30 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>drospirenone 3 mg + EE 30 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>drospirenone 3 mg + EE 30 vs</p> <p>drospirenone 3 mg + EE 20</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>insufficient data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Injectable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethisterone enanthate + E<sub>2</sub>V vs </p> <p>Nova‐T IUD</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Patch versus ring </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>transdermal patch vs</p> <p>vaginal ring</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/3</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup>Number of significant differences between study group divided by number of outcome measures (e.g., lumbar spine, femoral neck). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Summary of outcome data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/full#CD006033-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006033-tbl-0019"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Evidence quality</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison groups</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inadequate randomization<br/> and allocation<br/> concealment</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No blinding</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow up<br/> &lt;= 12 months<br/> (only BMD)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Losses<br/> &gt; 20%</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of<br/> evidence<sup>1</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Injectable (versus implant, injectable, or IUD)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA vs</p> <p>LNG 6‐rod implant</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>high</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + E<sub>2</sub>C vs </p> <p>DMPA + placebo</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + estrogen vs</p> <p>DMPA + placebo</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA‐subcutaneous vs</p> <p>DMPA‐intramuscular</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><i>Evidence quality from 4 DMPA trials</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>moderate</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Implants</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 6‐rod (standard) vs</p> <p>levonorgestrel 6‐rod (domestic)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>etonogestrel 1‐rod vs</p> <p>levonorgestrel 2‐rod</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>high</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><i>Evidence quality from 2 implant trials</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>moderate to high</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Combined oral contraceptives</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0002" title="BerensonAB , BreitkopfCR , GradyJJ , RickertVI , ThomasA . Effects of hormonal contraception on bone mineral density after 24 months of use. Obstetrics and Gynecology2004;103(5):899‐906. BerensonAB , RadeckiCM , GradyJJ , RickertVI , ThomasA . A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstetrics and Gynecology2001;98(4):576‐82. ">Berenson 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethindrone 1 mg + EE 35 μg vs</p> <p>desogestrel 150 μg + EE 30 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>very low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>desogestrel 150 μg + EE 30 μg vs</p> <p>cyproterone acetate 2 mg + EE 35 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0007" title="EndrikatJ , MihE , DusterbergB , LandK , GerlingerC , SchmidtW , et al. A 3‐year double‐blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception2004;69(3):179‐87. ">Endrikat 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 100 μg + EE 20 μg vs</p> <p>levonorgestrel 150 μg + EE 30 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0010" title="HartardM , KleinmondC , LuppaP , ZelgerO , EggerK , WisemanM , et al. Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception2006;74(5):367‐75. ">Hartard 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 100 μg + EE 20 μg vs</p> <p>desogestrel 150 μg + EE 20 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0017" title="RadM , KluftC , deKamML , MeijerP , CohenAF , GrubbGS , et al. Metabolic profile of a continuous versus a cyclic low‐dose combined oral contraceptive after one year of use. European Journal of Contraception and Reproductive Health Care2011;16(2):85‐94. TeichmannA , ApterD , EmerichJ , GrevenK , Klasa‐MazurkiewiczD , MelisGB , et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21‐day,cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open‐label trial. Contraception2009;80(6):504‐11. TeichmannAT , KluftC , GrubbG , ConstantineG , SpielmannD . Comparative trial of continuous‐use and 21‐day cyclic levonorgestrel and ethinyl estradiol oral contraceptive. Obstetrics and Gynecology2006;107:12S. Wyeth . Study evaluating levonorgestrel and ethinyl estradiol in oral contraception. http://clinicaltrials.gov/ct2/show/NCT00248963 (accessed 29 Mar 2011). ">Rad 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 90 μg + EE 20 μg (continuous) vs</p> <p>levonorgestrel 100 μg + EE 20 μg (cyclic)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0018" title="MerckSharpt , DohmeCorp . Effects on bone mineral density (BMD) of the combined oral contraceptive NOMAC‐E2 compared to a COC containing LNG/EE (292005) (P05765). http://clinicaltrials.gov/ct2/show/NCT00511342 (accessed 02 Jan 2014). SordalT , GrobP , VerhoevenC . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17beta‐estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstetricia Gynecologica Scandinavica2012;91(11):1279‐85. ">Sordal 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>nomegestrol 2.5 mg + 17ß estradiol 1.5 mg vs</p> <p>levonorgestrel 150 μg + EE 30 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>very low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0014" title="NappiC , DiSpiezio SardoA , AcunzoG , BifulcoG , TommaselliGA , GuidaM , et al. Effects of a low‐dose and ultra‐low‐dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2003;67(5):355‐9. ">Nappi 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>high</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 30 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>high</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0015" title="NappiC , DiSpiezio SardoA , GrecoE , TommaselliGA , GiordanoE , GuidaM . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstetrics and Gynecology2005;105(1):53‐60. ">Nappi 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>drospirenone 3 mg + EE 30 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0009" title="GarganoV , MassaroM , MorraI , FormisanoC , DiCarloC , NappiC . Effects of two low‐dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception2008;78(1):10‐5. ">Gargano 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>drospirenone 3 mg + EE 30 vs</p> <p>drospirenone 3 mg + EE 20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>unclear</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><i>Evidence quality from 11 COC studies</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>low</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Injectable or patch versus ring</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethisterone enanthate + E<sub>2</sub>V vs </p> <p>Nova‐T IUD</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>transdermal patch vs</p> <p>vaginal ring</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>high</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><i>Evidence quality from 2 trials of injectable or patch versus ring</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>moderate to high</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b><i>Overall evidence quality from 19 trials</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b><i>moderate</i> </b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Grade levels were high, moderate, low, or very low. RCTs were downgraded one level for each of the following: a) randomization sequence generation and allocation concealment: no information on either, or one was inadequate; b) no blinding; c) follow up &lt;= 12 months for BMD only; d) losses &gt;= 20% for primary analysis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Evidence quality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006033-tbl-0020"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analysis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study<sup>1</sup> </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison groups</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fracture</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bone mineral<br/> density<sup>2</sup> </b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biochemical<br/> markers<sup>2</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Injectable DMPA</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0013" title="NaessenT , OlssonSE , GudmundsonJ . Differential effects on bone density of progestogen‐only methods for contraception in premenopausal women. Contraception1995;52(1):35‐9. ">Naessen 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA vs</p> <p>levonorgestrel 6‐rod implant</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0004" title="CromerBA , LazebnikR , RomeE , StagerM , BonnyA , ZieglerJ , DebanneSM . Double‐blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. American Journal of Obstetrics and Gynecology2005;192(1):42‐7. ">Cromer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + E<sub>2</sub>C vs </p> <p>DMPA + placebo supplement</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/8</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0005" title="CundyT , AmesR , HorneA , ClearwaterJ , RobertsH , GambleG , et al. A randomized controlled trial of estrogen replacement therapy in long‐term users of depot medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism2003;88(1):78‐81. ">Cundy 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA + estrogen vs</p> <p>DMPA + placebo supplement</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/10</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0011" title="KaunitzAM , DarneyPD , RossD , WolterKD , SperoffL . Subcutaneous DMPA vs. intramuscular DMPA: a 2‐year randomized study of contraceptive efficacy and bone mineral density. Contraception2009;80(1):7‐17. ">Kaunitz 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DMPA subcutaneous vs</p> <p>DMPA intramuscular</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Implants</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0006" title="DiX , LiY , ZhangC , JiangJ , GuS . Effects of levonorgestrel‐releasing subdermal contraceptive implants on bone density and bone metabolism. Contraception1999;60(3):161‐6. ">Di 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>levonorgestrel 6‐rod (standard) vs</p> <p>levonorgestrel 6‐rod (domestic)</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0001" title="BahamondesL , Monteiro‐DantasC , Espejo‐ArceX , Dos Santos FernandesAM , Lui‐FilhoJF , PerrottiM , et al. A prospective study of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Human Reproduction2006;21(2):466‐70. Monteiro‐DantasC , Espejo‐ArceX , Lui‐FilhoJF , FernandesAM , MontieroI , BahamondesL . A three‐year longitudinal evaluation of the forearm bone density of users of etonogestrel‐ and levonorgestrel‐releasing contraceptive implants. Reproductive Health2007;4:11. [DOI: 10.1186/1742‐4755‐4‐11] ">Bahamondes 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>etonogestrel 1‐rod vs</p> <p>levonorgestrel 2‐rod</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/5</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Combined oral contraceptives</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0008" title="GaiL , JiaY , ZhangM , GaiP , WangS , ShiH , et al. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception2012;86(4):332‐6. ">Gai 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>desogestrel 150 μg + EE 30 μg vs</p> <p>cyproterone acetate 2 mg + EE 35 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/4</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0016" title="PaolettiAM , OrruM , FlorisS , ManniasM , VaccaAMB , AjossaS , et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception2000;61(4):259‐63. ">Paoletti 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 20 μg vs</p> <p>gestodene 75 μg + EE 30 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0003" title="CibulaD , SkrenkovaJ , HillM , StepanJJ . Low‐dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. European Journal of Endocrinology2012;166(6):1003‐11. ">Cibula 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>gestodene 75 μg + EE 30 μg vs</p> <p>gestodene 60 μg + EE 15 μg</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Combination injectable or patch versus ring</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0019" title="vonKesseruE , EtcheparebordaJJ , WikinskiR , BeierS . Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception2000;61(5):317‐22. ">Von Kesseru 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>norethisterone enanthate + E<sub>2</sub>V vs </p> <p>Nova‐T IUD</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/2</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006033-bbs2-0012" title="MassaroM , DiCarloC , GarganoV , FormisanoC , BifulcoG , NappiC . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception2010;81(3):209‐14. ">Massaro 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>transdermal patch vs</p> <p>vaginal ring</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐‐</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/1</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/3</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>Provided sufficient data for that outcome (<a href="#CD006033-tbl-0002">Table 4</a>) and the evidence was moderate or high quality (<a href="#CD006033-tbl-0019">Table 1</a>).<br/> <sup>2</sup>From <a href="#CD006033-tbl-0002">Table 4</a>: number of outcome measures showing a significant difference between study groups divided by number of outcome measures. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/information#CD006033-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Levonorgestrel‐releasing implants: Norplant versus Chinese implant</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Bone mineral density (L2 to L4) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.02, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bone mineral density (femoral neck) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.01, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Bone mineral density (trochanter) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.02, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Bone mineral density (Ward's triangle) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.00, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serum osteocalcin at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.58, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Serum alkaline phosphatase at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [‐13.29, 17.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Urine hydroxyproline/creatinine at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐2.86, 6.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Urine calcium/creatinine at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐20.12 [‐44.01, 3.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Levonorgestrel‐releasing implants: Norplant versus Chinese implant</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Bone mineral density (midshaft ulna) at 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.02, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Percent change in bone mineral density (midshaft ulna) by 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐0.56, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Bone mineral density (distal radius) at 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.02, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Percent change in bone mineral density (distal radius) by 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐1.09, ‐0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Bone mineral density (distal radius) at 36 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Etonogestrel‐releasing implant versus levonorgestrel‐releasing implant</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">DMPA 150 mg versus levonorgestrel‐releasing implant</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum alkaline phosphatase at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐1.21, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serum osteocalcin at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.44 [‐3.39, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serum calcium at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Urinary hydroxyproline/creatinine at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.30 [‐14.52, 29.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">DMPA 150 mg versus levonorgestrel‐releasing implant</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Percent change in bone mineral density (spine) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [1.80, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Percent change in bone mineral apparent density (spine) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.7 [1.60, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Percent change in bone mineral density (femoral neck) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.2 [1.36, 5.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Percent change in bone mineral apparent density (femoral neck) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [‐2.01, 4.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Percent change in bone mineral density (spine) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.6 [2.87, 6.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Percent change in bone mineral apparent density (spine) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.9 [3.11, 6.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Percent change in bone mineral density (femoral neck) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.8 [4.96, 14.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Percent change in bone mineral apparent density (femoral neck) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.10 [0.50, 13.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">DMPA 150 mg + estradiol cypionate 5 mg versus DMPA 150 mg + placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in bone mineral density (lumbar spine) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in bone mineral density (lumbar spine) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.02, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in bone mineral density (Ward's triangle) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in bone mineral density (Ward's triangle) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.00, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in bone mineral density (trochanter) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.01, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in bone mineral density (trochanter) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in bone mineral density (femoral neck) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in bone mineral density (femoral neck) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.02, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in bone mineral density (total body) by12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in bone mineral density (total body) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.01, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">DMPA 150 mg + conjugated estrogens 625 µg versus DMPA 150 mg + placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">DMPA‐SC 104 mg versus DMPA‐IM 150 mg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Decrease in total hip BMD &gt;= 5% from baseline (year 1) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.29, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Decrease in total hip BMD &gt;= 5% from baseline (year 2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.43, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Decrease in total hip BMD &gt;= 5% from baseline (year 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.56, 2.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 1) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.47, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.34, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Decrease in lumbar spine BMD &gt;= 5% from baseline (year 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.00, 4.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">DMPA‐SC 104 mg versus DMPA‐IM 150 mg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Norethindrone 1 mg + EE 35 µg versus desogestrel 150 µg + EE 30 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Percent change in bone mineral density (lumbar spine) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [0.42, 3.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Percent change in bone mineral density (lumbar spine) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [‐1.24, 2.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Norethindrone 1 mg + EE 35 µg versus desogestrel 150 µg + EE 30 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in BMD of lumbar spine by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in BMD of lumbar spine by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in BMD of femoral neck by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in BMD of femoral neck by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Desogestrel 150 µg + EE 30 µg versus cyproterone acetate 2 mg + EE 35 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Bone mineral density (lumbar spine) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐17.84, 13.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bone mineral density (lumbar spine) at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐18.29, 15.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Bone mineral density (lumbar spine) at 36 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.53 [‐17.27, 10.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Percent change in bone mineral density (lumbar spine) by 36 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐3.00, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Percent change in serum alkaline phosphatase (36 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐57.80 [‐160.03, 44.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Percent change in cross‐linked N‐telopeptides (36 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.70 [‐31.90, 16.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Levonorgestrel 100 µg + EE 20 µg versus levonorgestrel 150 µg + EE 30 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Percent change in areal bone mineral density (lumbar spine) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [‐0.11, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Percent change in areal bone mineral density (femoral neck) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐2.42, 2.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Percent change in serum bone‐specific alkaline phosphatase by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.31 [3.91, 26.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Percent change in serum osteocalcin by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.71 [‐2.49, 17.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Percent change in serum cross‐linked telopeptides by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.39 [‐8.41, 41.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Levonorgestrel 100 µg + EE 20 µg versus desogestrel 150 µg + EE 20 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Nomegestrol 2.5 mg + estradiol 1.5 mg versus levonorgestrel 150 µg + EE 30 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in z‐score of lumbar spine after cycle 26 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.22, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in z‐score of femoral neck after cycle 26 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.16, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Nomegestrol 2.5 mg + estradiol 1.5 mg versus levonorgestrel 150 µg + EE 30 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary pyridinoline at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐1.65, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary deoxypyridinoline at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.37, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serum osteocalcin at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [‐1.87, 5.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Gestodene 75 µg + EE 20 µg versus gestodene 75 µg + EE 30 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Drospirenone 3 mg + EE 30 µg versus gestodene 75 µg + EE 30 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Bone mineral density (lumbar spine) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Drospirenone 3 mg + EE 30 µg versus gestodene 75 µg + EE 30 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Drospirenone 3 mg + EE 30 µg versus drospirenone 3 mg + EE 20 µg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Bone mineral density (lumbar spine) at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.09, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Drospirenone 3 mg + EE 30 µg versus drospirenone 3 mg + EE 20 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Lumbar spine BMD at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.09, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary pyridinoline at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.65, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary deoxypyridinoline at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.24, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serum osteocalcin at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.26, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Transdermal patch (norelgestromin 150 µg plus EE 20 µg) versus vaginal ring (etonogestrel 120 µg plus EE 15 µg)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006033-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Norethisterone enanthate 50 mg + estradiol valerate 5 mg versus Nova T IUD</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Percent change in bone mineral density (lumbar spine) by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.7 [‐3.08, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Percent change in bone mineral density (lumbar spine) by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐2.74, 2.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Norethisterone enanthate 50 mg + estradiol valerate 5 mg versus Nova T IUD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006033.pub5/references#CD006033-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006033.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006033-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006033-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006033-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006033-note-0001">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pl#CD006033-note-0003">Polski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006033\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006033\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006033\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006033\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006033\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006033.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006033.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006033.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006033.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006033.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717939056"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006033.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717939059"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006033.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc428bdbf9377',t:'MTc0MDcxNzkzOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 